GlassScriptPhysician profile
Samuel J Evans
NPI 1992744452
$15,308.38
in general payments reported to CMS, 2019-2025
18 companies · $9,316 in 2025
The $9,316 reported for 2025 was more than what 92% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,149 · 2021: $247 · 2022: $1,035 · 2023: $1,887 · 2024: $674 · 2025: $9,316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,651 · Food and Beverage: $2,975 · Consulting Fee: $1,902 · Travel and Lodging: $1,350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,650.50 |
| Food and Beverage | $2,974.64 |
| Consulting Fee | $1,902.00 |
| Travel and Lodging | $1,349.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,796.37 | 2022-2025 | |
| Genzyme Corporation | $3,371.95 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $2,234.02 | 2019-2025 | Tezspire, Fasenra |
| Noah Medical Corporation | $731.00 | 2023 | |
| Glaxosmithkline, LLC. | $429.95 | 2022-2025 | Arexvy, Nucala, Trelegy Ellipta |
| Takeda Pharmaceuticals U.S.A., INC. | $390.22 | 2023-2025 | Gammagard, Aralast, Glassia |
| Insmed, INC. | $310.93 | 2019-2025 | Arikayce |
| Genentech USA, INC. | $250.00 | 2019 | |
| Pharming Healthcare, INC. | $142.78 | 2024 | Joenja, Ruconest |
| Abbvie INC. | $125.00 | 2022 | |
| Shionogi INC | $121.18 | 2025 | |
| Shire North American Group INC | $99.46 | 2019 | |
| Medtronic, INC. | $94.37 | 2024 | Illumisite |
| Boehringer Ingelheim Pharmaceuticals, INC. | $94.24 | 2022 | |
| Covidien LP | $48.47 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $32.78 | 2023 | Inspire |
| Abiomed | $22.05 | 2019 | |
| Ethicon INC. | $13.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.